The effects of teriparatide on bone microarchitecture as determined by high resolution magnetic resonance imaging and digital topological analysis.
Phase of Trial: Phase IV
Latest Information Update: 04 Jun 2014
At a glance
- Drugs Teriparatide (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 10 Jun 2017 Biomarkers information updated
- 19 Sep 2011 Results presented at the 33rd Annual Meeting of the American Society for Bone and Mineral Research (ASBMR-2011), according to an Eli Lilly media release.
- 23 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.